Two Sigma Investments
INDV icon

Two Sigma Investments’s Indivior Pharmaceuticals INDV Stock Holding History

Two Sigma Investments’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.36M Buy
175,767
+60,790
+53% +$2.01M ﹤0.01% 1928
2025
Q4 		$4.13M Sell
114,977
-30,857
-21% -$942K 0.01% 1884
2025
Q3 		$3.52M Buy
145,834
+103,243
+242% +$2.16M 0.01% 1737
2025
Q2 		$628K Buy
42,591
+8,114
+24% +$94.5K ﹤0.01% 2482
2025
Q1 		$329K Sell
34,477
-76,403
-69% -$803K ﹤0.01% 2679
2024
Q4 		$1.38M Buy
110,880
+2,237
+2% +$23K ﹤0.01% 1967
2024
Q3 		$1.06M Buy
108,643
+60,068
+124% +$704K ﹤0.01% 2088
2024
Q2 		$783K Buy
48,575
+28,312
+140% +$511K ﹤0.01% 2121
2024
Q1 		$434K Buy
+20,263
New +$381K ﹤0.01% 2399

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments's INDV Position: Q1 2026 in Review

Two Sigma Investments increased its Indivior Pharmaceuticals (INDV) stake by 53% in Q1 2026, buying an estimated $2.01M and bringing the position to 175,767 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Two Sigma Investments first reported a position in INDV in Q1 2024 and has held it in 9 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Two Sigma Investments held 175,767 shares of Indivior Pharmaceuticals worth $5.36M as of Q1 2026.
  • Two Sigma Investments bought 60,790 Indivior Pharmaceuticals shares in Q1 2026, an estimated $2.01M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1928 holding.
  • Two Sigma Investments first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.